Early and Long-term Outcome after Open Surgical Suprarenal Aortic Fenestration in Patients with Complicated Acute

Z Szeberin1, E Dósa1, M Fehérvári1

  • 1Department of Vascular Surgery, Cardiovascular Centre, Semmelweis University, Budapest, Hungary.

Insights

Open surgical suprarenal aortic fenestration (OSSAF) for complicated acute type B aortic dissection has acceptable early mortality and low paraplegia rates. However, late mortality remains a concern, often linked to aortic rupture.

Area of Science:

  • Cardiovascular Surgery
  • Thoracic Surgery
  • Vascular Surgery
  • Aortic Diseases

Background:

  • Complicated acute type B aortic dissection (CABAD) presents significant mortality and morbidity risks.
  • Traditional open surgical repair and newer endovascular techniques are treatment options.
  • Open surgical suprarenal aortic fenestration (OSSAF) is an alternative for specific CABAD cases.

Purpose of the Study:

  • To evaluate early and long-term mortality and morbidity in CABAD patients treated with OSSAF.
  • To identify risk factors affecting long-term prognosis after OSSAF.
  • To compare OSSAF outcomes with other treatment modalities for CABAD.

Main Methods:

  • Retrospective cohort study of 52 CABAD patients treated between 2002 and 2008.
  • Forty-two patients underwent OSSAF; ten had aortic graft replacement.
  • Follow-up included clinical examination and computed tomography angiography for up to 84 months.

Main Results:

  • Indications for OSSAF included malperfusion (40%), pain/hypertension (50%), and false lumen enlargement (10%).
  • Thirty-day mortality was 21.4%; 5-year survival was 70.6%.
  • Late mortality (19%) was primarily due to aortic rupture; no paraplegia occurred. Nine patients (21%) required further intervention.

Conclusions:

  • OSSAF offers acceptable early mortality and a low rate of paraplegia in CABAD.
  • Late mortality is a significant concern, often associated with aortic rupture.
  • While stent grafting is preferred, OSSAF remains a viable option for select patients unsuitable for endovascular repair.
Abstract